Follow
Trevin Kurtanich
Trevin Kurtanich
Postdoctoral Scholar, University of Chicago
Verified email at uchicago.edu
Title
Cited by
Cited by
Year
Pancreatic cancer gene therapy delivered by nanoparticles
T Kurtanich, N Roos, G Wang, J Yang, A Wang, EJ Chung
SLAS TECHNOLOGY: Translating Life Sciences Innovation 24 (2), 151-160, 2019
252019
LFA-1 activation enriches tumor-specific T cells in a cold tumor model and synergizes with CTLA-4 blockade
A Hickman, J Koetsier, T Kurtanich, MC Nielsen, G Winn, Y Wang, ...
The Journal of clinical investigation 132 (13), 2022
222022
Development and validation of a novel organotypic in vitro model of the tumor-lymph-immune interface for predicting immunotherapy resistance
R Zhou, R Weathered, T Kurtanich, R Mezyk-Kopec, A Mansurov, ...
CANCER RESEARCH 80 (11), 68-68, 2020
12020
Engineered IL-7 synergizes with IL-12 immunotherapy to prevent T cell exhaustion and promote memory without exacerbating toxicity
S Kang, A Mansurov, T Kurtanich, HR Chun, AJ Slezak, LR Volpatti, ...
Science Advances 9 (48), eadh9879, 2023
2023
Membrane-localized neoantigens predict the efficacy of cancer immunotherapy
Z Goldberger, S Hauert, K Chang, T Kurtanich, AT Alpar, G Repond, ...
Cell Reports Medicine 4 (8), 2023
2023
Prophylactic and therapeutic use of synthetically glycosylated antigens to limit allergic airway disease
JEG Medellin, TWM Ung, TR Kurtanich, JW Reda, T Wang, K Chang, ...
The Journal of Immunology 210 (1_Supplement), 67.23-67.23, 2023
2023
VEGFR-3 Stimulation on LECs Boosts Type 2 Immunity After Vaccination
TR Kurtanich, JEG Medellin, MA Swartz
The Journal of Immunology 210 (1_Supplement), 79.18-79.18, 2023
2023
Manipulating the VEGF-C/VEGFR-3 Axis to Modulate Vaccine Outcomes and Antitumor Immunity
TR Kurtanich
The University of Chicago, 2023
2023
55P Mutations localized at the membrane predict immunotherapeutic efficacy in cancer treatment
Z Goldberger, S Hauert, K Chang, T Kurtanich, AT Alpar, JA Hubbell, ...
Immuno-Oncology and Technology 16, 2022
2022
Membrane-Localized Mutations Predict the Efficacy of Cancer Immunotherapy
PS Briquez, S Hauert, Z Goldberger, T Kurtanich, AT Alpar, G Repond, ...
medRxiv, 2022.05. 28.22275728, 2022
2022
VEGFR3-driven pulmonary lymphangiogenesis exacerbates induction of bronchus-associated lymphoid tissue in allergic airway disease
JE Gomez Medellin, MK Hollinger, J Rosenberg, K Blaine, T Kurtanich, ...
The Journal of Immunology 208 (1_Supplement), 109.24-109.24, 2022
2022
The system can't perform the operation now. Try again later.
Articles 1–11